**Author details**

**Funding**

№16-45-03007.

**Abbreviations**

AAV adeno-associated virus

CHD coronary heart disease

HGF hepatocyte growth factor HIFs hypoxia-induced factors HO-1 heme oxygenase-1 IC intermittent claudication MI myocardial infarction MMP matrix metalloproteinase MSC mesenchymal stem cell(s) PAD peripheral artery disease

EC endothelial cell(s) ECM extracellular matrix

CS cell sheet

(a/b)FGF (acidic/basic) fibroblast growth factor ABI ankle-brachial (pressure) index

354 Physiologic and Pathologic Angiogenesis - Signaling Mechanisms and Targeted Therapy

AD-MSC adipose-derived mesenchymal stem cells BM-MNC bone marrow mononuclear cell(s) BM-MSC bone marrow mesenchymal stem cell(s)

G-CSD granulocyte colony-stimulating factor

PB-MNC peripheral blood mononuclear cell(s)

pressure

pDNA plasmid DNA

PlGF placental growth factor SDF-1α Stromal cell-derived factor-1α

SMC smooth muscle cell(s) TcO<sup>2</sup> transcutaneous O2

vWF von Willebrand factor

PDGF platelet-derived growth factor

TGF transforming growth factor uPA urokinase plasminogen activator VEGF vascular endothelial growth factor

Study and publication was supported by a grant from Russian Scientific Foundation (RSF)

Pavel Igorevich Makarevich1-3 \* and Yelena Viktorovna Parfyonova1, 3

\*Address all correspondence to: pmakarevich@mc.msu.ru

1 Institute of Regenerative Medicine, Lomonosov Moscow State University, Moscow, Russia

2 Faculty of Medicine, Lomonosov Moscow State University, Moscow, Russia

3 Institute of Experimental Cardiology, Russian Cardiology Research and Production Complex, Russia
